Avaksim

Roman name

Avaxim #

The composition and the form of

0.5 ml suspension for injection with one dose of inactivated vaccine for the prevention of hepatitis are hepatitis A (H5N1 GBM, in the cultured diploid human cells-MRC_5, inactivated formaldehyde), 160 antigenic units (the antigen was using internal referens-standarta); in the injection of one dose (0.5 ml) in a carton filled one.

Characteristics

Inactivated vaccine for the prevention of hepatitis A.

Of drugs

Immunostimulating. Select active specific immunity to the virus of hepatitis A.

Clinical pharmacology

< c2 span onmouseover="_tipon(this)" onmouseout="_tipoff()">Vaccination delineated in the incubation period of hepatitis A, may prove to be ineffective, and the syndrome can lead to a weak immune response. Vaccination drug does not prevent viral hepatitis another etiology and infections caused gepatotropnami other microorganisms.

Indications

Prevention of infection caused by a virus hepatitis A from those of 2 years and over from different risk groups : neimmunizirovannah travelling in the endemic areas (with a high level of hepatitis A), at the risk of occupational exposure (staff care for the sick, sewer and water services, food industry, food), including special risk group (patients with hemophilia and Multiple gemotransfuzyami, drug addicts, homosexuals).

Pregnancy and lactation

No data on the effects of the vaccine in humans, the fetus and infant. The vaccination during pregnancy or breast-feeding should be taken only on the basis of assessment of the real risk of contracting hepatitis A.

Contraindications

Гиперчувствительност ь (incl. to formaldegidu), increased body temperature, acute or chronic degenerative diseases (in these cases vaccinations to defer to normalise).

Side-Effects

The pain and redness, it is very rarely sealed at the place of; Modest increase body temperature; Weakness, headache, muscle ffa and joint pain; Diarrhoeal disorders, a small (forming) increase in liver transaminaz.

Patient interaction

The effect weakens immunosupressus therapy. A vaccine is compatible with immunoglobulinami subject to the use of various sites for injection.

Precautions

The confused with the other vaccines in a single sprite. Be wary drug use in patients with liver diseases. Avoid at / in the (need to verify that the needle is not named in onychectomy receptacle), in agodicnae muscle (the thickness variability fat layer), or / to the (possibly decline in the immune response). In difficult cases, we recommend consultation doctor, a specialist. The use of the vaccine after their expiry date.

Dosing and Administration

B / m (recommended introduction to the deltoid muscle shoulder), c / to the (recommended imposition of patients with trombozitopenia or bleeding); In the usual dose for 0.5 ml (each of). Primary vaccination produced by merely one dose of vaccine; Revackzinatiu spend six months.

Directory → Immunotropona funds → Vaccines, serums, fagi → Avaksim